Actively Recruiting
Magnetic Resonance Spectroscopy to Identify Brain Biomarkers in Adults with Type 3 Gaucher Disease
Led by University of Minnesota · Updated on 2026-08-04
5
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying neurometabolite profiles in adults with Type 3 Gaucher Disease GD3 who have neurological involvement. The study aims to identify new biomarkers using magnetic resonance spectroscopy MRS that can show how patients respond to treatment. It also explores connections between neurometabolites and disease factors like genotype, enzyme levels, and other GD biomarkers. This is an observational study with no intervention, focusing on measuring brain chemicals related to oxidative stress and inflammation using MRS scans. Participants will undergo MRS to collect data on neurometabolites without receiving any treatment as part of the study. Participants will be adults aged 18 to 80 with GD3 who are medically stable. The study involves brain scans using MRS and blood draws to assess disease markers. Researchers will evaluate baseline neurometabolite profiles and their relationships to disease characteristics. The study spans several years, with assessments to monitor these biomarkers and disease parameters over time.
CONDITIONS
Brief Title
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
Research Team
R
Reena Kartha, PhD
R
Raghu Sharma, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here